TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07333547: Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

Sponsor: Idoven 1903 S.L. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 200000 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07333547 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07333547 Rescue Dossier →